HKEX: 2591
Interim Report 2026
View original source (HKEXnews)
Earlier from Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
- Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa
- Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions